NR566 | NR566 Advanced Pharmacology for Care
of the Family Wk 1 Midterm v1 | Questions with
Correct Answers and Expert Explanation for Each
Question | Chamberlain
1. Which pharmacokinetic process is primarily affected when a drug is administered
orally and undergoes extensive metabolism in the liver before reaching systemic
circulation?
A. Distribution
B. Excretion
C. Absorption
D. First-pass metabolism
Correct Answer: D
Expert Explanation: First-pass metabolism occurs when a drug is metabolized in
the liver or gut wall before it reaches the systemic circulation, significantly reducing
its bioavailability. This effect is most prominent with oral medications that are
absorbed into the portal venous system. Understanding this process is crucial for
determining the appropriate dosage and route of administration for various drugs.
2. A drug with a high affinity for albumin will most likely result in which of the
following clinical scenarios in a patient with severe malnutrition?
A. Increased risk of drug toxicity due to higher levels of free drug
,B. Decreased therapeutic effect due to rapid excretion
C. Decreased distribution to peripheral tissues
D. Lower risk of side effects because there is less protein to bind
Correct Answer: A
Expert Explanation: Albumin is the primary protein in the blood that binds to
many drugs, rendering the bound portion pharmacologically inactive. In
malnourished patients with low albumin levels, there is less protein available for
binding, leading to an increase in the concentration of free, active drug in the
plasma. This elevation in free drug levels can significantly increase the risk of
toxicity and adverse reactions even at standard doses.
3. When prescribing a medication that is known as a Cytochrome P450 (CYP450)
enzyme inducer, the provider should anticipate which effect on a co-administered
drug that is a substrate of the same enzyme?
A. Increased plasma levels of the substrate drug
B. Decreased plasma levels and potential therapeutic failure of the substrate drug
C. Decreased rate of metabolism for the substrate drug
D. No change in the metabolism of the substrate drug
Correct Answer: B
,Expert Explanation: Enzyme inducers increase the activity and production of
specific CYP450 enzymes, which speeds up the metabolism of substrate drugs. As a
result, the concentration of the substrate drug in the blood decreases more rapidly
than normal, which can lead to a loss of therapeutic efficacy. Healthcare providers
must monitor for subtherapeutic effects and potentially increase the dose of the
substrate drug when an inducer is added to the regimen.
4. The ‘Steady State’ of a drug is typically reached after how many half-lives of
consistent dosing?
A. 1 to 2 half-lives
B. 4 to 5 half-lives
C. 10 to 12 half-lives
D. Immediately after the loading dose
Correct Answer: B
Expert Explanation: Steady state is the point at which the rate of drug
administration equals the rate of drug elimination, resulting in a constant plasma
concentration. It generally takes approximately 4 to 5 half-lives of a drug
administered at regular intervals to reach this equilibrium. This concept is vital for
determining when to measure peak and trough levels to evaluate the effectiveness
and safety of a medication.
, 5. Which of the following describes an ‘Agonist’ medication?
A. A drug that binds to a receptor and activates it to produce a biological response
B. A drug that binds to a receptor and blocks the endogenous ligand
C. A drug that permanently inactivates a receptor site
D. A drug that has no intrinsic activity but high affinity
Correct Answer: A
Expert Explanation: An agonist is a molecule that mimics the action of a naturally
occurring substance by binding to a specific receptor and triggering a physiological
response. It possesses both affinity for the receptor and intrinsic activity to initiate a
change in cellular function. In contrast, an antagonist would bind to the receptor but
fail to activate it, thereby blocking the response of an agonist.
6. Which statement is true regarding the prescriptive authority of Nurse Practitioners
(NPs) according to the DEA?
A. NPs can prescribe any medication in all states without a DEA number
B. NPs must have a DEA number to prescribe any non-controlled substance
C. The DEA does not oversee the prescriptive authority of NPs, only physicians
D. NPs must have a DEA number to prescribe controlled substances, as regulated by
state and federal laws
of the Family Wk 1 Midterm v1 | Questions with
Correct Answers and Expert Explanation for Each
Question | Chamberlain
1. Which pharmacokinetic process is primarily affected when a drug is administered
orally and undergoes extensive metabolism in the liver before reaching systemic
circulation?
A. Distribution
B. Excretion
C. Absorption
D. First-pass metabolism
Correct Answer: D
Expert Explanation: First-pass metabolism occurs when a drug is metabolized in
the liver or gut wall before it reaches the systemic circulation, significantly reducing
its bioavailability. This effect is most prominent with oral medications that are
absorbed into the portal venous system. Understanding this process is crucial for
determining the appropriate dosage and route of administration for various drugs.
2. A drug with a high affinity for albumin will most likely result in which of the
following clinical scenarios in a patient with severe malnutrition?
A. Increased risk of drug toxicity due to higher levels of free drug
,B. Decreased therapeutic effect due to rapid excretion
C. Decreased distribution to peripheral tissues
D. Lower risk of side effects because there is less protein to bind
Correct Answer: A
Expert Explanation: Albumin is the primary protein in the blood that binds to
many drugs, rendering the bound portion pharmacologically inactive. In
malnourished patients with low albumin levels, there is less protein available for
binding, leading to an increase in the concentration of free, active drug in the
plasma. This elevation in free drug levels can significantly increase the risk of
toxicity and adverse reactions even at standard doses.
3. When prescribing a medication that is known as a Cytochrome P450 (CYP450)
enzyme inducer, the provider should anticipate which effect on a co-administered
drug that is a substrate of the same enzyme?
A. Increased plasma levels of the substrate drug
B. Decreased plasma levels and potential therapeutic failure of the substrate drug
C. Decreased rate of metabolism for the substrate drug
D. No change in the metabolism of the substrate drug
Correct Answer: B
,Expert Explanation: Enzyme inducers increase the activity and production of
specific CYP450 enzymes, which speeds up the metabolism of substrate drugs. As a
result, the concentration of the substrate drug in the blood decreases more rapidly
than normal, which can lead to a loss of therapeutic efficacy. Healthcare providers
must monitor for subtherapeutic effects and potentially increase the dose of the
substrate drug when an inducer is added to the regimen.
4. The ‘Steady State’ of a drug is typically reached after how many half-lives of
consistent dosing?
A. 1 to 2 half-lives
B. 4 to 5 half-lives
C. 10 to 12 half-lives
D. Immediately after the loading dose
Correct Answer: B
Expert Explanation: Steady state is the point at which the rate of drug
administration equals the rate of drug elimination, resulting in a constant plasma
concentration. It generally takes approximately 4 to 5 half-lives of a drug
administered at regular intervals to reach this equilibrium. This concept is vital for
determining when to measure peak and trough levels to evaluate the effectiveness
and safety of a medication.
, 5. Which of the following describes an ‘Agonist’ medication?
A. A drug that binds to a receptor and activates it to produce a biological response
B. A drug that binds to a receptor and blocks the endogenous ligand
C. A drug that permanently inactivates a receptor site
D. A drug that has no intrinsic activity but high affinity
Correct Answer: A
Expert Explanation: An agonist is a molecule that mimics the action of a naturally
occurring substance by binding to a specific receptor and triggering a physiological
response. It possesses both affinity for the receptor and intrinsic activity to initiate a
change in cellular function. In contrast, an antagonist would bind to the receptor but
fail to activate it, thereby blocking the response of an agonist.
6. Which statement is true regarding the prescriptive authority of Nurse Practitioners
(NPs) according to the DEA?
A. NPs can prescribe any medication in all states without a DEA number
B. NPs must have a DEA number to prescribe any non-controlled substance
C. The DEA does not oversee the prescriptive authority of NPs, only physicians
D. NPs must have a DEA number to prescribe controlled substances, as regulated by
state and federal laws
